CONMED CORPORATION Payments for Restructuring
CONMED CORPORATION (CNMD) reported Payments for Restructuring of $5.63 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-26.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForRestructuring · last filed 2018-02-26
- CONMED CORPORATION payments for restructuring for the quarter ending 2017-12-31 was $207.00K, a 94.58% decline year-over-year.
- CONMED CORPORATION payments for restructuring for the quarter ending 2017-09-30 was $1.51M, a 118.35% increase year-over-year.
- CONMED CORPORATION payments for restructuring for the quarter ending 2017-06-30 was $516.00K, a 81.57% decline year-over-year.
- CONMED CORPORATION payments for restructuring for the quarter ending 2017-03-31 was $3.40M, a 51.10% decline year-over-year.
- CONMED CORPORATION payments for restructuring for fiscal 2017 was $5.63M, a 60.51% decline from fiscal 2016.
- CONMED CORPORATION payments for restructuring for fiscal 2016 was $14.27M, a 37.28% decline from fiscal 2015.
- CONMED CORPORATION payments for restructuring for fiscal 2015 was $22.75M, a 38.84% increase from fiscal 2014.
- CONMED CORPORATION payments for restructuring for fiscal 2014 was $16.39M, a 10.81% decline from fiscal 2013.
| Period end | Payments for Restructuring 3 month | Payments for Restructuring 3 month as first filed | Payments for Restructuring 6 month | Payments for Restructuring 6 month as first filed | Payments for Restructuring 9 month | Payments for Restructuring 9 month as first filed | Payments for Restructuring 12 month | Payments for Restructuring 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2017-12-31 | $207.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $1.72M derived: sum of 2 quarters · filed 2018-02-26 | $2.23M derived: sum of 3 quarters · filed 2018-02-26 | $5.63M 10-K · filed 2018-02-26 | ||||
| 2017-09-30 | $1.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $2.03M derived: sum of 2 quarters · filed 2017-11-02 | $5.43M 10-Q · filed 2017-11-02 | $9.25M derived: sum of 4 quarters · filed 2018-02-26 | ||||
| 2017-06-30 | $516.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-27 | $3.92M 10-Q · filed 2017-07-27 | $7.74M derived: sum of 3 quarters · filed 2018-02-26 | $8.43M derived: sum of 4 quarters · filed 2018-02-26 | ||||
| 2017-03-31 | $3.40M 10-Q · filed 2017-04-27 | $7.22M derived: sum of 2 quarters · filed 2018-02-26 | $7.91M derived: sum of 3 quarters · filed 2018-02-26 | $10.71M derived: sum of 4 quarters · filed 2018-02-26 | ||||
| 2016-12-31 | $3.82M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $4.51M derived: sum of 2 quarters · filed 2018-02-26 | $7.31M derived: sum of 3 quarters · filed 2018-02-26 | $14.27M 10-K · filed 2018-02-26 | $14.47M 10-K · filed 2017-02-27 | |||
| 2016-09-30 | $692.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $3.49M derived: sum of 2 quarters · filed 2017-11-02 | $10.45M 10-Q · filed 2017-11-02 | $15.16M derived: sum of 4 quarters · filed 2018-02-26 | ||||
| 2016-06-30 | $2.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-27 | $9.76M 10-Q · filed 2017-07-27 | $14.46M derived: sum of 3 quarters · filed 2018-02-26 | $19.61M derived: sum of 4 quarters · filed 2018-02-26 | ||||
| 2016-03-31 | $6.96M 10-Q · filed 2017-04-27 | $11.66M derived: sum of 2 quarters · filed 2018-02-26 | $16.81M derived: sum of 3 quarters · filed 2018-02-26 | $21.82M derived: sum of 4 quarters · filed 2018-02-26 | ||||
| 2015-12-31 | $4.71M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $9.85M derived: sum of 2 quarters · filed 2018-02-26 | $14.87M derived: sum of 3 quarters · filed 2018-02-26 | $22.75M 10-K · filed 2018-02-26 | ||||
| 2015-09-30 | $5.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-28 | $10.16M derived: sum of 2 quarters · filed 2016-10-28 | $18.04M 10-Q · filed 2016-10-28 | $7.52M 10-Q · filed 2015-10-23 | $32.40M derived: sum of 4 quarters · filed 2017-02-27 | |||
| 2015-06-30 | $5.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-28 | $12.90M 10-Q · filed 2016-07-28 | $4.55M 10-Q · filed 2015-07-27 | $27.26M derived: sum of 3 quarters · filed 2017-02-27 | $27.40M derived: sum of 4 quarters · filed 2017-02-27 | |||
| 2015-03-31 | $7.88M 10-Q · filed 2016-05-02 | $2.17M 10-Q · filed 2015-04-24 | $22.25M derived: sum of 2 quarters · filed 2017-02-27 | $22.39M derived: sum of 3 quarters · filed 2017-02-27 | $22.45M derived: sum of 4 quarters · filed 2017-02-27 | |||
| 2014-12-31 | $14.36M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $14.50M derived: sum of 2 quarters · filed 2017-02-27 | $14.57M derived: sum of 3 quarters · filed 2017-02-27 | $16.39M 10-K · filed 2017-02-27 | $2.31M 10-K · filed 2015-02-23 | |||
| 2014-09-30 | $140.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-24 | $208.00K derived: sum of 2 quarters · filed 2014-10-24 | $2.02M 10-Q · filed 2014-10-24 | $23.73M derived: sum of 4 quarters · filed 2016-02-23 | ||||
| 2014-06-30 | $68.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-25 | $1.89M 10-Q · filed 2014-07-25 | $23.59M derived: sum of 3 quarters · filed 2016-02-23 | $23.00M derived: sum of 4 quarters · filed 2016-02-23 | ||||
| 2014-03-31 | $1.82M 10-Q · filed 2014-04-25 | $23.53M derived: sum of 2 quarters · filed 2016-02-23 | $22.93M derived: sum of 3 quarters · filed 2016-02-23 | $21.73M derived: sum of 4 quarters · filed 2016-02-23 | ||||
| 2013-12-31 | $21.71M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-23 | $21.12M derived: sum of 2 quarters · filed 2016-02-23 | $19.91M derived: sum of 3 quarters · filed 2016-02-23 | $18.37M 10-K · filed 2016-02-23 | $4.89M 10-K · filed 2014-02-24 | |||
| 2013-09-30 | -$592.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-28 | -$1.79M derived: sum of 2 quarters · filed 2013-10-28 | -$3.34M 10-Q · filed 2013-10-28 | |||||
| 2013-06-30 | -$1.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-29 | -$2.75M 10-Q · filed 2013-07-29 | ||||||
| 2013-03-31 | -$1.54M 10-Q · filed 2013-04-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |